A Review on Autoimmune Diseases: Recent Advances and Future Perspectives

Abstract

Autoimmune diseases represent a diverse group of disorders characterized by immune-mediated attacks on the body’s own tissues and organs. This review provides a comprehensive overview of autoimmune diseases, covering their definition, classification, epidemiology, etiology, pathogenesis, clinical manifestations, current treatments, and future research directions. Autoimmune diseases can be categorized into organ-specific (e.g., type 1 diabetes, Hashimoto's thyroiditis) and systemic (e.g., systemic lupus erythematosus, rheumatoid arthritis) conditions, each with distinct clinical presentations and underlying mechanisms. Genetic predisposition, environmental triggers, and immunological dysregulation play critical roles in disease development. Common symptoms include fatigue, joint pain, skin manifestations, and organ-specific dysfunction, contributing to significant morbidity and impaired quality of life. Current treatment strategies encompass immunosuppressive therapies, disease-modifying drugs, and emerging biologic agents targeting specific immune pathways. Advances in genomics, immunology, and precision medicine offer promising avenues for personalized diagnosis and treatment optimization. Future research directions include further elucidating disease heterogeneity, identifying novel biomarkers, and developing targeted immunotherapies to achieve long-term remission and improve patient outcomes. Understanding the complex interplay of genetic, environmental, and immunological factors is crucial for advancing therapeutic approaches and mitigating the global burden of autoimmune diseases. Enhanced collaboration across disciplines and continued investment in research are essential to translate these insights into clinical practice and benefit patients worldwide.